Dr. Mitchell Sanders is a Serial Entrepreneur, C-Level Executive, and Scientist developing advanced wound care products for the past 30 years with 70+ peer reviewed publications and world-wide patents (Google Scholar citations, https://biturl.top/YRruYn). Over the past 20 years Dr. Sanders has secured over $65M in strategic partnerships for new product development for his lab. Dr. Sanders was founder and CEO of ECI Biotech (1998-2016) and his company developed the first infection diagnostic for chronic wounds (Bacterial Status), sold by WoundChek Labs. Mitch later worked at Alira Health as CSO, Board Member, and Founder/CEO of two additional startups (WoundForce Inc., and Firefly Innovations, LLC) that he sold to Alira Health. In 2023, Dr. Sanders became Chief Executive Officer of ProDevLabs LLC, a Premier Wound Care R&D and Preclinical CRO in Southborough MA. Dr. Sanders earned his undergraduate degree in Biology with a Minor in Latin Language and Literature from Boston University. He later received a MS and PhD in Biology and Biomedical Sciences at Worcester Polytechnic Institute (WPI) and then did two Postdocs at MIT/Whitehead Institute in Biochemistry and Host Pathogen Interactions.

Mitch is an active member of the Wound Healing Society and is co-sponsor and Moderator of the WoundShark Program.